Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate-to-severe hidradenitis suppurativa

被引:9
|
作者
Molinelli, Elisa [1 ]
Sapigni, Claudia [1 ]
Simonetti, Oriana [1 ]
Radi, Giulia [1 ]
Gambini, Daisy [1 ]
Maurizi, Andrea [1 ]
Rizzetto, Giulio [1 ]
D'Agostino, Giovanni Marco [1 ]
Offidani, Annamaria [1 ]
机构
[1] Polytech Marche Univ, Dept Clin & Mol Sci, Dermatol Unit, Ancona, Italy
关键词
D O I
10.1111/dth.15645
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [41] An evaluation of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa
    Stergianou, Dimitra
    Kanni, Theodora
    Damoulari, Christina
    Giamarellos-Bourboulis, Evangelos J.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (04) : 225 - 232
  • [42] EFFICACY AND SAFETY OF DUPILUMAB IN CHILDREN AGED 6 MONTHS TO 5 YEARS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Worrell, Richard
    Paller, Amy S.
    Siegfried, Elaine C.
    Simpson, Eric L.
    Wollenberg, Andreas
    Gonzalez, Mercedes E.
    Sidbury, Robert
    Lockshin, Benjamin
    Dubost-Brama, Ariane
    Bansal, Ashish
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 31 - 32
  • [43] Real-world effectiveness and safety of dupilumab in managing children and adolescents with moderate-to-severe atopic dermatitis
    Marshall, Claire
    Littlewood, Zoe
    Herety, Nichola
    Heal, Calvin
    Sharif, Jennifer
    Clayton, Tim
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 196 - 196
  • [44] Efficacy and safety of dupilumab in Japanese adults with moderate-to-severe atopic dermatitis: a subanalysis of three clinical trials
    Katoh, N.
    Kataoka, Y.
    Saeki, H.
    Hide, M.
    Kabashima, K.
    Etoh, T.
    Igarashi, A.
    Imafuku, S.
    Kawashima, M.
    Ohtsuki, M.
    Fujita, H.
    Arima, K.
    Takagi, H.
    Chen, Z.
    Shumel, B.
    Ardeleanu, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (01) : 39 - 51
  • [45] Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
    Fargnoli, M. C.
    Esposito, M.
    Ferrucci, S.
    Girolomoni, G.
    Offidani, A.
    Patrizi, A.
    Peris, K.
    Costanzo, A.
    Malara, G.
    Pellacani, G.
    Romanelli, M.
    Amerio, P.
    Cristaudo, A.
    Flori, M. L.
    Motolese, A.
    Betto, P.
    Patruno, C.
    Pigatto, P.
    Sirna, R.
    Stinco, G.
    Zalaudek, I.
    Bianchi, L.
    Boccaletti, V.
    Cannavo, S. P.
    Cusano, F.
    Lembo, S.
    Mozzillo, R.
    Gallo, R.
    Potenza, C.
    Rongioletti, F.
    Tiberio, R.
    Grieco, T.
    Micali, G.
    Persechino, S.
    Pettinato, M.
    Pucci, S.
    Savi, E.
    Stingeni, L.
    Romano, A.
    Argenziano, G.
    Calabrese, Giulia
    Campanati, Anna
    Caruso, Cristiano
    Chello, Camilla
    De Pasquale, Tiziana
    Di Costanzo, Luisa
    Dini, Valentina
    De Pasquale, Rocco
    Del Giglio, Micol
    Fracassi, Giovanna
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (05) : 507 - 513
  • [46] Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
    Blauvelt, Andrew
    Teixeira, Henrique D.
    Simpson, Eric L.
    Costanzo, Antonio
    De Bruin-Weller, Marjolein
    Barbarot, Sebastien
    Prajapati, Vimal H.
    Lio, Peter
    Hu, Xiaofei
    Wu, Tianshuang
    Liu, John
    Ladizinski, Barry
    Chu, Alvina D.
    Eyerich, Kilian
    JAMA DERMATOLOGY, 2021, 157 (09) : 1047 - 1055
  • [47] Long-term safety of adalimumab for patients with moderate-to-severe hidradenitis suppurativa
    Tzanetakou, Vassiliki
    Stergianou, Dimitra
    Giamarellos-Bourboulis, Evangelos J.
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (04) : 381 - 393
  • [48] Dupilumab provides long-term improvement in pruritus in children with severe atopic dermatitis and adolescents and adults with moderate-to-severe atopic dermatitis
    Cork, Michael J.
    Yosipovitch, Gil
    Silverberg, Jonathan I.
    Praestgaard, Amy
    Zhang, Haixin
    Wang, Zhixiao
    Rossi, Ana B.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 79 - 79
  • [49] Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a critical appraisal
    Thomson, J.
    Wernham, A. G. H.
    Williams, H. C.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (04) : 897 - 902
  • [50] Expert opinion on management of moderate-to-severe atopic dermatitis in Qatar
    Steinhoff, Martin
    Adeli, Mehdi
    Riad, Hassan
    Allam, Mohamed
    Hazem, Ahmad
    Alsmadi, Ra'ed
    Kamal, Adel Mohamed
    Ibrahim, Waad
    Al-Nesf, Maryam Ali
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)